TABLE OF CONTENTS
Volume 28, Issue 44 (5 November 2009)
Original Articles
p53 responsive elements in human retrotransposons
C R Harris, A DeWan, A Zupnick, R Normart, A Gabriel, C Prives, A J Levine and J Hoh
Oncogene 28: 3857-3865; advance online publication, August 31, 2009; doi:10.1038/onc.2009.246
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis
A Seckinger, T Mei
ner, J Moreaux, H Goldschmidt, G M Fuhler, A Benner, M Hundemer, T Rème, J D Shaughnessy Jr, B Barlogie, U Bertsch, J Hillengass, A D Ho, V Pantesco, A Jauch, J De Vos, J F Rossi, T Möhler, B Klein and D Hose
Oncogene 28: 3866-3879; advance online publication, August 31, 2009; doi:10.1038/onc.2009.257
Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling
N Ashley and J Poulton
Oncogene 28: 3880-3891; advance online publication, August 17, 2009; doi:10.1038/onc.2009.242
Macrophage-derived IL-1
stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D3
P Kaler, L Augenlicht and L Klampfer
Oncogene 28: 3892-3902; advance online publication, August 24, 2009; doi:10.1038/onc.2009.247
The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation
K M Shah, S E Stewart, W Wei, C B J Woodman, J D O'Neil, C W Dawson and L S Young
Oncogene 28: 3903-3914; advance online publication, August 31, 2009; doi:10.1038/onc.2009.249
The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis
N Baum, C Schiene-Fischer, M Frost, M Schumann, K Sabapathy, O Ohlenschläger, F Grosse and B Schlott
Oncogene 28: 3915-3925; advance online publication, August 31, 2009; doi:10.1038/onc.2009.248
Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines
S-K Leivonen, R Mäkelä, P Östling, P Kohonen, S Haapa-Paananen, K Kleivi, E Enerly, A Aakula, K Hellström, N Sahlberg, V N Kristensen, A-L Børresen-Dale, P Saviranta, M Perälä and O Kallioniemi
Oncogene 28: 3926-3936; advance online publication, August 17, 2009; doi:10.1038/onc.2009.241
Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer
X-F Li, P-J Yan and Z-M Shao
Oncogene 28: 3937-3948; advance online publication, August 24, 2009; doi:10.1038/onc.2009.245
